Cargando…

NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach

In high grade serous ovarian cancer patients with peritoneal involvement and unfavorable outcome would benefit from targeted therapies. The aim of this study was to find a druggable target against peritoneal metastasis. We constructed a planar—scale free small world—co-association gene expression ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bekos, Christine, Muqaku, Besnik, Dekan, Sabine, Horvat, Reinhard, Polterauer, Stephan, Gerner, Christopher, Aust, Stefanie, Pils, Dietmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562934/ https://www.ncbi.nlm.nih.gov/pubmed/31137558 http://dx.doi.org/10.3390/cancers11050698

Ejemplares similares

An Analysis of Nectin-4 (PVRL4) in Penile Squamous Cell Carcinoma
por: Grass, G.Daniel, et al.
Publicado: (2023)

The Tumor-Associated Marker, PVRL4 (Nectin-4), is the Epithelial Receptor for Morbilliviruses
por: Delpeut, Sebastien, et al.
Publicado: (2014)

Adherens junction protein nectin-4 (PVRL4) is the epithelial receptor for measles virus
por: Mühlebach, Michael D., et al.
Publicado: (2011)

Tumor Cell Marker PVRL4 (Nectin 4) Is an Epithelial Cell Receptor for Measles Virus
por: Noyce, Ryan S., et al.
Publicado: (2011)

Neutrophil Extracellular Trap Formation Correlates with Favorable Overall Survival in High Grade Ovarian Cancer
por: Muqaku, Besnik, et al.
Publicado: (2020)

PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome
por: Bekos, Christine, et al.
Publicado: (2021)

Small RNAs and the competing endogenous RNA network in high grade serous ovarian cancer tumor spread
por: Bachmayr-Heyda, Anna, et al.
Publicado: (2016)

Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer
por: Auer, Katharina, et al.
Publicado: (2016)

Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancer
por: Aust, Stefanie, et al.
Publicado: (2017)

Two different, mutually exclusively distributed, TP53 mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?
por: Sukhbaatar, Nyamdelger, et al.
Publicado: (2017)

Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients
por: Grech, Christina T., et al.
Publicado: (2022)

Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome
por: Auer, Katharina, et al.
Publicado: (2015)

The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer
por: Aust, Stefanie, et al.
Publicado: (2013)

A Global Gene Body Methylation Measure Correlates Independently with Overall Survival in Solid Cancer Types
por: Pils, Dietmar, et al.
Publicado: (2020)

A role for PVRL4-driven cell–cell interactions in tumorigenesis
por: Pavlova, Natalya N, et al.
Publicado: (2013)

Peptidomic Approaches and Observations in Neurodegenerative Diseases
por: Muqaku, Besnik, et al.
Publicado: (2022)

Expression of nectin-4 in prostate cancer
por: Ordu, Melike, et al.
Publicado: (2023)

Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium
por: Aust, Stefanie, et al.
Publicado: (2014)

p63-dependent and independent mechanisms of nectin-1 and nectin-4 regulation in the epidermis
por: Mollo, Maria Rosaria, et al.
Publicado: (2015)

Diagnostic and Prognostic Roles of Urine Nectin-2 and Nectin-4 in Human Bladder Cancer
por: Miyake, Makito, et al.
Publicado: (2023)

Reduced LDL-Cholesterol and Reduced Total Cholesterol as Potential Indicators of Early Cancer in Male Treatment-Naïve Cancer Patients With Pre-cachexia and Cachexia
por: Zwickl, Hannes, et al.
Publicado: (2020)

Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis
por: Bekos, Christine, et al.
Publicado: (2018)

Defining Models to Classify between Benign and Malignant Adnexal Masses Using Routine Laboratory Parameters
por: Reiser, Elisabeth, et al.
Publicado: (2022)

Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target?
por: Tanaka, Yuka, et al.
Publicado: (2021)

Expression and clinical significance of Nectin-4 in hepatocellular carcinoma
por: Ma, Jie, et al.
Publicado: (2016)

The Prognostic Role of Expression of Nectin-4 in Esophageal Cancer
por: Lin, Xiaolong, et al.
Publicado: (2019)

NECTIN4: A Novel Therapeutic Target for Melanoma
por: Tanaka, Yuka, et al.
Publicado: (2021)

Expression of nectin-4 in papillary renal cell carcinoma
por: Zschäbitz, Stefanie, et al.
Publicado: (2022)

Nectin4 is a potential therapeutic target for asthma
por: Lee, Pureun-Haneul, et al.
Publicado: (2022)

Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases
por: Zila, Nina, et al.
Publicado: (2018)

The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer
por: Bartl, Thomas, et al.
Publicado: (2020)

Proteomic and Metabolomic Analyses Reveal Contrasting Anti-Inflammatory Effects of an Extract of Mucor Racemosus Secondary Metabolites Compared to Dexamethasone
por: Meier, Samuel M., et al.
Publicado: (2015)

Molecular Subtyping of Serous Ovarian Cancer Based on Multi-omics Data
por: Zhang, Zhe, et al.
Publicado: (2016)

Tracing the evolution of nectin and nectin-like cell adhesion molecules
por: Duraivelan, Kheerthana, et al.
Publicado: (2020)

Use of SLAM and PVRL4 and Identification of Pro-HB-EGF as Cell Entry Receptors for Wild Type Phocine Distemper Virus
por: Melia, Mary M., et al.
Publicado: (2014)

Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
por: Garczyk, Stefan, et al.
Publicado: (2022)

Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery
por: Bekos, Christine, et al.
Publicado: (2019)

Nectin-4 is widely expressed in head and neck squamous cell carcinoma
por: Sanders, Christine, et al.
Publicado: (2022)

Prognostic value of nectin-4 in human cancers: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2023)

Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers
por: Vannini, Andrea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_66ff3nqifjtn8ftnlkqj130poj